Covid 19 is an illness caused by the recently discovered Coronavirus. The virus causes an unparalleled range of coagulopathy related disorders in affected patients. In this paper, we aim to understand the linkage between abnormal clot formation and the Coronavirus. The clotting parameters of Covid infected patients were studied to elucidate a better understanding of the coagulation disorder. A comparative analysis of the diagnostic reports collected from five different labs across the world aids us comprehend the elevated levels of coagulation parameters observed in these Covid infected patients. Initial coagulopathy of COVID 19 has been characterized as increased levels of prothrombin time, activated partial thromboplastin time, and platelet counts followed by elevated concentrations of D dimer and fibrin degradation products. Coagulation assays used to determine these clotting factors were through invasive methods. Conventional coagulation assays being invasive had their drawbacks taken care of with the advent of non-invasive methods. With the current scenario of this pandemic, the necessity for technological improvements in non-invasive and point of care testing methods are substantial.

1.
N.
Tang
,
D.
Li
,
X.
Wang
, and
Z.
Sun
,
J Thromb Haemost
18
,
844
(
2020
).
2.
F.A.
Klok
,
M.J.H.A.
Kruip
,
N.J.M.
van der Meer
,
M.S.
Arbous
,
D.A.M.P.J.
Gommers
,
K.M.
Kant
,
F.H.J.
Kaptein
,
J.
van Paassen
,
M.A.M.
Stals
,
M.V.
Huisman
, and
H.
Endeman
,
Thrombosis Research
191
,
145
(
2020
).
3.
J.
Llitjos
,
M.
Leclerc
,
C.
Chochois
,
J.
Monsallier
,
M.
Ramakers
,
M.
Auvray
, and
K.
Merouani
,
J Thromb Haemost
18
,
1743
(
2020
).
4.
S.
Araya
,
M.A.
Mamo
,
Y.G.
Tsegay
,
A.
Atlaw
,
A.
Aytenew
,
A.
Hordofa
,
A.E.
Negeso
,
M.
Wordofa
,
T.
Niguse
,
M.
Cheru
, and
Z.
Tamir
,
PLoS ONE
16
,
e0252939
(
2021
)
5.
S.
Biswas
,
V.
Thakur
,
P.
Kaur
,
A.
Khan
,
S.
Kulshrestha
, and
P.
Kumar
,
Medical Hypotheses
146
,
110371
(
2021
).
6.
L.
Nicolai
,
A.
Leunig
,
S.
Brambs
,
R.
Kaiser
,
T.
Weinberger
,
M.
Weigand
,
M.
Muenchhoff
,
J.C.
Hellmuth
,
S.
Ledderose
,
H.
Schulz
,
C.
Scherer
,
M.
Rudelius
,
M.
Zoller
,
D.
Höchter
,
O.
Keppler
,
D.
Teupser
,
B.
Zwißler
,
M.
von Bergwelt-Baildon
,
S.
Kääb
,
S.
Massberg
,
K.
Pekayvaz
, and
K.
Stark
,
Circulation
142
,
1176
(
2020
).
7.
R.I.
Litvinov
,
N.G.
Evtugina
,
A.D.
Peshkova
,
S.I.
Safiullina
,
I. A.
Andrianova
,
A. I.
Khabirova
,
C.
Nagaswami
,
R.R.
Khismatullin
,
S.S.
Sannikova
, and
J.W.
Weisel
,
Sci Rep
11
,
16290
(
2021
).
8.
H. G.
Hawes
,
B. A.
Cotton
, and
L. A.
Mcelroy
,
Encyclopedia of Trauma Care.
2015
.
9.
M.
Roshal
, “
Activated Partial Thromboplastin Time
,” in
Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects: Second Edition
,
2013
.
10.
M.D.
Lancé
,
Thrombosis J
13
,
1
(
2015
)
11.
V.
Ignjatovic
, “
Thrombin Clotting Time,
2013
.
12.
A.
Tripodi
,
Clinical Chemistry
62
,
699
(
2016
).
13.
P.O.
Sevenet
and
F.
Depasse
,
sInt J Lab Hem
39
,
561
(
2017
)
14.
M.
Gurram
and
S.
Pulivarthi
,
North Am J Med Sci
6
,
491
(
2014
).
15.
J.N.
Harr
,
E.E.
Moore
,
A.
Ghasabyan
,
T.L.
Chin
,
A.
Sauaia
,
A.
Banerjee
, and
C.C.
Silliman
,
Shock
39
,
45
(
2013
).
16.
A. C.
Ivy
,
D.
Nelson
, and
G.
Bucher
, “
The standardization of certain factors in the cutaneous„ venostasis, bleeding time technique
,”
J. Lab. Clin. Med.
,
1941
17.
“©|1964 Nature Publishing Group,”
1964
18.
E. J.
Favaloro
,
Am J Hematol
94
,
1290
(
2019
)
19.
H.
Karapetian
, “
Reptilase time (RT
),”
Methods Mol. Biol.
,
2013
20.
I. M. B.
Francischetti
and
M. Reyes
Gil
, “
Diagnostic Use of Venoms
,” in
Transfusion Medicine and Hemostasis
,
2019
.
21.
C.
Incorvia
, “
( 12 ) United States Patent
,” vol.
2
, no.
12
, pp.
1
4
,
2015
.
22.
G.
Nowak
,
Pathophysiol Haemos Thromb
33
,
173
(
2003
).
23.
D.M.
Butler
,
H.B.
Kirkpatrick
, and
J.H.
Staehlin
,
Transfusion Science
14
,
i
(
1993
)
24.
Y.
Lerman
,
JBM
113
(
2011
).
25.
V.
Kalchenko
,
A.
Brill
,
I.
Fine
, and
A.
Harmelin
, in edited by
G.L.
Coté
and
A.V.
Priezzhev
(
San Jose, CA
,
2007
), p.
644508
.
26.
D.
Giannis
,
I.A.
Ziogas
, and
P.
Gianni
,
Journal of Clinical Virology
127
,
104362
(
2020
).
27.
N.
Tang
,
H.
Bai
,
X.
Chen
,
J.
Gong
,
D.
Li
, and
Z.
Sun
,
J Thromb Haemost
18
,
1094
(
2020
).
28.
H.
Han
,
L.
Yang
,
R.
Liu
,
F.
Liu
,
K.
Wu
,
J.
Li
,
X.
Liu
, and
C.
Zhu
,
Clinical Chemistry and Laboratory Medicine (CCLM)
58
,
1116
(
2020
).
29.
B.
Sayad
and
Z.
Rahimi
,
East Mediterr Health J.
26
,
999
(
2020
).
30.
X.
Jin
,
Y.
Duan
,
T.
Bao
,
J.
Gu
,
Y.
Chen
,
Y.
Li
,
S.
Mao
,
Y.
Chen
, and
W.
Xie
,
PLoS ONE
15
,
e0241329
(
2020
).
This content is only available via PDF.
You do not currently have access to this content.